<PAGE>

       AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON NOVEMBER 20, 2000
================================================================================

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                        --------------------------------

                                   FORM 10-QSB

                        --------------------------------
(Mark One)

[X]      QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
         ACT OF 1934
         For the quarterly period ended September 30, 2000

[ ]      TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT
         For the transition period from _______________ to _______________

                        Commission file number 000-27915

                              GENIUS PRODUCTS, INC.
                              A NEVADA CORPORATION
           (Name of small business issuer as specified in its charter)

             NEVADA                                               33-0852923
(State or other jurisdiction of                                 (IRS Employer
 incorporation or organization)                              Identification No.)

                            11250 EL CAMINO REAL #100
                               SAN DIEGO, CA 92127
                    (Address of principal executive officers)

                                 (858) 793-8840
                           (Issuer's telephone number)

                                 NOT APPLICABLE
              (Former name, former address and former fiscal year,
                         if changed since last report)

Check where the issuer (1) filed all reports required to be filed by Section 13
or 15(d) of the Exchange Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes  [X]  No  [ ]

There were 15,190,975 shares outstanding of the registrant's Common Stock as of
November 15, 2000.

Transitional small business disclosure format (check one): Yes  [ ]  No  [X]

================================================================================

                                       1
<PAGE>

                              GENIUS PRODUCTS, INC.


                                      INDEX

                                                                            PAGE

PART I          Financial Information                                         3

   Item 1  Financial Statements                                               3

           Condensed Consolidated Balance Sheet at  September 30, 2000
                  (unaudited)                                                 3
           Condensed Consolidated Statements of Operations
                  For the Nine Months Ended September 30, 2000
                  and September 30, 1999 (unaudited)                          4
           Condensed Consolidated Statements of Operations
                  For the Three Months Ended September 30, 2000
                  and September 30, 1999 (unaudited)                          5
           Condensed Consolidated Statements of Cash Flow
                  For the Nine Months Ended September 30, 2000
                  and September 30, 1999 (unaudited)                          6
           Notes to Condensed Consolidated Financial Statements (unaudited)   7

   Item 2  Management's Discussion and Analysis of Financial
                  Condition and Results of Operations                         7

PART II         Other Information                                             9

   Item 1  Legal Proceedings                                                  9

   Item 2  Changes in Securities and Use of Proceeds                          9

   Item 3  Defaults Upon Senior Securities                                    10

   Item 4  Submission of Matters to a Vote of Security Holders                10

   Item 5  Other Information                                                  10

   Item 6  Exhibits and Reports on Form 8-K                                   10

SIGNATURES                                                                    11


                                       2
<PAGE>

                         PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

                      CONDENSED CONSOLIDATED BALANCE SHEET
                                   (UNAUDITED)

                                                              SEPTEMBER 30, 2000
                                                              ------------------
                          ASSETS

Current assets:
 Cash and equivalents                                             $      30,707
 Accounts receivable, net of allowance for
   doubtful accounts and sales returns of $56,220                       182,248
 Inventories                                                            222,826
 Other current assets                                                    31,702
                                                                  --------------
   Total current assets                                                 467,483

 Property and equipment, net of accumulated depreciation
   of $49,879                                                            92,620
 Production masters, net of accumulated amortization
   of $154,907                                                          218,124
 Patents and trademarks, net of accumulated
   amortization of $4,919                                                29,385
 Deposits and other                                                      75,913
                                                                  --------------
                                                                  $     883,525
                                                                  ==============

              LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:
 Loans from shareholders                                          $      46,667
 Accounts payable                                                       310,330
 Accrued payroll and related expenses                                   113,949
 Accrued other expenses                                                 122,389
                                                                  --------------
   Total current liabilities                                            593,335

Redeemable common stock                                                 461,260

Commitments and contingencies                                                 -

Stockholders' equity:
 Common stock, $.001 par value; 25,000,000 shares
 authorized: 14,410,975 shares outstanding                               14,410
 Additional paid-in capital                                           6,499,531
 Unamortized Stock Options                                               (6,275)
 Stock subscriptions receivable                                         (86,000)
 Accumulated deficit                                                 (6,592,736)
                                                                  --------------
   Total stockholders' equity                                          (171,070)
                                                                  --------------
                                                                  $     883,525
                                                                  ==============

                                       3
<PAGE>

                     GENIUS PRODUCTS, INC. AND SUBSIDIARIES
                 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                   (UNAUDITED)

                                               NINE MONTHS ENDED SEPTEMBER 30,
                                             -----------------------------------
                                                  2000                1999
                                             ---------------     ---------------

Revenues:
   Music                                     $      638,731      $      765,793
   Licensing                                         37,500                   -
   Jewelry/Other                                    436,656             683,822
                                             ---------------     ---------------
   Total revenues                                 1,112,887           1,449,615
                                             ---------------     ---------------

Costs and expenses:
 Cost of sales:
   Music                                            231,101             182,044
   Licensing                                         11,250                   -
   Jewelry/Other                                    350,070             659,274
 Sales and marketing                                457,723             756,449
 Infomercial                                              -                   -
 Product and web development                        346,142             184,914
 General and administrative                       1,351,520           1,098,981
                                             ---------------     ---------------
   Total costs and expenses                       2,747,806           2,881,662
                                             ---------------     ---------------

   Loss from operations                          (1,634,919)         (1,432,047)

Gain on disposal                                         70                   -
Interest expense                                    (16,976)            (19,819)
                                             ---------------     ---------------

   Loss before provision for income taxes        (1,651,825)         (1,451,866)

Provision for income taxes                             (800)               (800)
                                             ---------------     ---------------

   Net loss                                  $   (1,652,625)     $   (1,452,666)
                                             ===============     ===============

Basic and diluted loss per common share:

   Net loss per share                        $        (0.14)     $        (0.15)
                                             ===============     ===============

   Basic and diluted weighted average shares     12,241,060           9,384,046
                                             ===============     ===============

                                       4
<PAGE>
                     GENIUS PRODUCTS, INC. AND SUBSIDIARIES
                 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                   (UNAUDITED)


                                                THREE MONTHS ENDED SEPTEMBER 30,
                                                ------------------------------
                                                    2000              1999
                                                -------------    -------------

Revenues:
   Music                                        $     79,146     $    373,630
   Licensing                                               -                -
   Jewelry/Other                                     186,451          318,181
                                                -------------    -------------
   Total revenues                                    265,597          691,811
                                                -------------    -------------

Costs and expenses:
 Cost of sales:
   Music                                              23,890           88,672
   Licensing                                               -                -
   Jewelry/Other                                     165,608          305,454
 Sales and marketing                                  53,360          377,123
 Product and web development                          93,251           57,862
 General and administrative                          420,633          455,293
                                                -------------    -------------
   Total costs and expenses                          756,742        1,284,404
                                                -------------    -------------

   Loss from operations                             (491,145)        (592,593)

Gain on disposal                                           -                -
Interest expense                                     (11,505)          (6,911)
                                                -------------    -------------

   Loss before provision for income taxes           (502,650)        (599,504)

Provision for income taxes                                 -                -
                                                -------------    -------------

   Net loss                                         (502,650)        (599,504)
                                                =============    =============

Basic and diluted loss per common share:

   Net loss per share                                  (0.04)           (0.06)
                                                =============    =============

   Basic and diluted weighted average shares      11,998,884       10,055,715
                                                =============    =============

                                       5

<PAGE>
<TABLE>

                           GENIUS PRODUCTS INC. AND SUBSIDIARIES
                      CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                        (UNAUDITED)
<CAPTION>

                                                           NINE MONTHS ENDED SEPTEMBER 30,
                                                        ----------------------------------
                                                             2000                1999
                                                        ---------------    ---------------
<S>                                                     <C>                <C>
Cash flows from operating activities
      Net loss                                          $   (1,652,625)    $   (1,452,666)
      Adjustments to reconcile net loss to net cash
      used by operating activities:
      Depreciation and amortization                             80,395             49,300
      Common stock issued for services                         153,508            222,781
      Stock option costs                                        13,624
      Changes in assets and liabilities:
      (Increase) decrease in:
      Accounts receivable                                      390,145           (314,335)
      Inventories                                              (47,679)            (6,342)
      Deposits and other                                       (38,295)            86,056
      Increase (decrease) in:
      Accounts payable                                        (244,172)          (248,191)
      Accrued payroll and other expenses                       110,685            228,951
                                                        ---------------    ---------------
      Net cash used by operating activities                 (1,234,414)        (1,434,446)
                                                        ---------------    ---------------

Cash flows from investing activities
      Patents and trademarks                                   (11,969)            (4,875)
      Development of production masters                              -           (296,107)
      Purchase of property and equipment                        (6,393)           (81,888)
                                                        ---------------    ---------------
      Net cash used in investing activities                    (18,362)          (382,870)
                                                        ---------------    ---------------

Cash flows from financing activities:
      Payments on notes payable                                 (1,000)                 -
      Borrowings of notes payable                              265,000
      Proceeds from issuance of common stock                   810,100          1,759,087
      Exercise of stock options                                163,750                  -
                                                        ---------------    ---------------
      Net cash provided by financing activities              1,237,850          1,759,087
                                                        ---------------    ---------------

Net (decrease) increase in cash and equivalents                (14,926)           (58,229)

Cash at beginning of period                                     45,633            121,157
                                                        ---------------    ---------------

Cash at end of period                                   $       30,707     $       62,928
                                                        ===============    ===============

Non-cash investing and financing activities:
      Repayment of loans by issuance
      of common stock                                   $      317,400     $            -
                                                        ===============    ===============
</TABLE>

                                       6
<PAGE>

                              GENIUS PRODUCTS, INC.

                     NOTES TO CONDENSED FINANCIAL STATEMENTS
                                   (UNAUDITED)


NOTE A : BASIS OF PRESENTATION

         The accompanying unaudited condensed consolidated financial statements
of Genius Products, Inc. have been prepared by the Company pursuant to the rules
and regulations of the Securities and Exchange Commission.

         The information furnished herein reflects all adjustments, consisting
of only normal recurring accruals and adjustments which are, in the opinion of
management, necessary to fairly state the operating results for the respective
periods. Certain information and footnote disclosures normally included in
annual financial statements prepared in accordance with generally accepted
accounting principles have been omitted pursuant to such rules and regulations.
The notes to the condensed financial statements should be read in conjunction
with the notes to the consolidated financial statements contained in the
Company's Form 10-KSB for the year ended December 31, 1999. Company management
believes that the disclosures are sufficient for interim financial reporting
purposes.

ITEM 2  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
        OF OPERATIONS

         THE FOLLOWING DISCUSSION OF OUR FINANCIAL CONDITION AND RESULTS OF
OPERATIONS SHOULD BE READ IN CONJUNCTION WITH THE FINANCIAL STATEMENTS AND NOTE
A TO THE FINANCIAL STATEMENTS INCLUDED ABOVE. THIS DISCUSSION CONTAINS
FORWARD-LOOKING STATEMENTS THAT RELATE TO FUTURE EVENTS OR THE COMPANY'S FUTURE
FINANCIAL PERFORMANCE AND INVOLVE KNOWN AND UNKNOWN RISKS, UNCERTAINTIES AND
OTHER FACTORS THAT MAY CAUSE THE COMPANY'S OR THE INDUSTRY'S ACTUAL RESULTS,
LEVELS OF ACTIVITY, PERFORMANCE OR ACHIEVEMENTS TO BE MATERIALLY DIFFERENT FROM
ANY FUTURE RESULTS, LEVELS OF ACTIVITY, PERFORMANCE OR ACHIEVEMENTS EXPRESSED OR
IMPLIED BY THESE FORWARD-LOOKING STATEMENTS.

         The three and nine months ended September 30, 2000.

         Revenues consist primarily of music (Baby Genius) product sales to
wholesale customers and via the internet to retail customers, and charges to
customers for shipping and handling, net of product returns and discounts.
Commencing the quarter ended June 30, 2000 the company recognized royalty
revenue related to licensing the Baby Genius trademark. In addition, revenues
include sales of jewelry products, net of returns.

         Total revenues decreased by 62% ($426,214) to $265,597 for the three
months ended September 30, 2000 from $691,811 for the three months ended
September 30, 1999. Total revenues decreased 23% ($336,728) to $1,112,887 for
the nine months ended September 30, 2000 from $1,449,615 for the nine months
ended September 30,1999.

         Music sales decreased by 79% ($294,484) to $79,146 for the three months
ended September 30, 2000 from $373,630 for the three months ended September 30,
1999. Music sales decreased 16% ($127,062) to $638,731 for the nine months ended
September 30, 2000 from $765,793 for the nine months ended September 30, 1999.
Reasons for the decrease in music sales included the fact that orders for the
holiday season that were expected in the third quarter of 2000 were received in
the fourth quarter 2000. The company also introduced new art work and packaging
in the third quarter of 2000 across the entire Baby Genius product line and
purchase orders were deferred pending completion of the change-over. Sales from
our web site were $9,023 and $131,552 for the three and nine months ending
September 30, 2000. There were no significant sales from our web site for the
three and nine months ended September 30, 1999. In the nine months ended
September 30, 2000 the company recognized licensing revenues of $37,500 relating
to the granting of a master toy license under our Baby Genius licensing program.
There were no licensing revenues for the nine months ended September 30, 1999.
Jewelry and other sales decreased 41% ($131,730) to $186,451

                                       7
<PAGE>

for the three months ended September 30, 2000 from $318,181 for the three months
ended September 30, 1999. Jewelry and other sales decreased 36% ($247,166) to
$436,656 for the nine months ended September 30, 2000 from $683,822 for the nine
months ended September 30, 1999. For both periods the reduction in sales was as
a result of reduced marketing efforts as management focused on developing the
music business.

         Cost of sales consist primarily of the costs of products sold to
customers, packaging and shipping costs and commissions relating to licensing
revenues. Cost of sales for music products was 30% of music sales ($23,890) and
36% of music sales ($231,101) for the three and nine months ended September 30,
2000 compared to 24% ($88,672) and 24% ($182,044) for the same periods in 1999.
The resulting decrease in profit margin to 70% for the three months ended
September 30, 2000 from 76% for the three months ended September 30, 1999 and
the decrease to 64% for the nine months ended September 30, 2000 from 76% for
the nine months ended September 30, 1999, was due to special promotional offers
to customers purchasing from our web site and the lowering of our retail sales
price. Cost of sales for jewelry products and other sales was 89% ($165,608) of
related sales and 80% ($350,070) of related sales for the three and nine months
ended September 30, 2000 respectively, compared to 96% ($305,454) and 96%
($659,274) for the same periods in 1999.

         Sales and marketing expense consist of costs for consultants, marketing
personnel and promotional activities. Sales and marketing expenses decreased by
86% ($323,763) to $53,360 for the three months ended September 30, 2000 from
$377,123 for the three months ended September 30, 1999. Sales and marketing
expenses decreased by 39% ($298,726) to $457,723 for the nine months ended
September 30, 2000 from $756,449 for the nine months ended September 30, 1999.
These decreases are as a result of the company declining to renew its contract
with our spokesperson and as well declining to retain consultants engaged in
prior periods.

         Infomercial expenses of $53,750 incurred in the nine months ended
September 30, 1999 related to costs for the Astrology Network product line,
which was discontinued in March 1999.

         Product and web development expenses consist of personnel, consultants
and services in the development of the Baby Genius web site and product line.
Product and web development costs increased by 61% ($35,389) to $93,251 for the
three months ended September 30, 2000 from $57,862 for the three months ended
September 30, 1999. Product and web development costs increased by 87%
($161,228) to $346,142 for the nine months ended September 30, 2000 from
$184,914 for the nine months ended September 30, 1999. The increase was
primarily due to expenses in the development of the Baby Genius web site and
product line.

         General and administrative expenses consist of payroll and related
costs for executive and administrative personnel, professional services and
other general corporate expenses. General and administrative expenses decreased
by 8% ($34,660) to $420,633 from $455,293 for the three months ended September
30, 2000. This decrease was primarily due to the company conserving funds.
General and administrative expenses increased by 23% ($252,539) to $1,351,520
for the nine months ended September 30, 2000 from $1,098,981 for the nine months
ended September 30, 1999. This increase was due to a rise in personnel costs and
audit, accounting, legal and professional fees related to audited financial
statements for 1999, preparation and filing of our Form 10- KSB and other
filings with the Securities and Exchange Commission, and services related to
fund raising activities.

         Interest expense consists of costs related to short-term loans.
Interest expense increased by 66% ($4,594) to $11,505 for the three months ended
September 30, 2000 from $6,911 for the three months ended September 30, 1999.
This increase reflects an increase in short-term debt for the quarter
subsequently converted into equity. Interest expense decreased by 14% ($2,843)
to $16,976 for the nine months ended September 30, 2000 from $19,819 for the
nine months ended September 30, 1999. The decrease in the nine month period
reflects a general decrease in short-term loans over the same period in 1999.

                                       8
<PAGE>

LIQUIDITY AND CAPITAL RESOURCES

         During the nine months ended September 30, 2000 we obtained financing
through a private placement offering, the exercise of stock options and the
issuance of short-term convertible debt. In the private placement offering the
company issued 1,876,667 shares at a price of $0.50 per share, and raised cash
proceeds of $810,100 net of finders' fees, legal costs and shares issued in
payment of a company loan of $52,400 owed to an investor in the private
placement. In addition the company raised $163,750 from the exercise of stock
options and $265,000 from the issuance of short-term convertible debt.

         Net cash used in operating activities was $1,234,414 and $1,434,446 for
the nine months ended September 30, 2000 and September 30, 1999 respectively.
Net operating cash flows for the nine months ended September 30, 2000 were
primarily attributable to operating losses of $1,652,625 and a decrease in
accounts payable of $244,172. This was partially offset by a decrease in
accounts receivable of $390,145, non-cash charges for depreciation and
amortization and stock issued for services. Net operating cash flows for the
nine months ended September 30, 1999 were primarily attributable to operating
losses of $1,452,666, and a decrease in accounts payable of $248,191. This was
partially offset by a decrease in accounts receivable of $314,335 and non-cash
charges for depreciation and amortization and stock issued for services.

         Net cash used in investing activities was $18,362 and $382,870 for the
nine months ended September 30, 2000 and September 30, 1999 respectively. Cash
used in investing activities for the nine months ended September 30, 2000 was
attributable to the purchase of property and equipment ($6,393) and filing trade
marks ($11,969) in respect of the Baby Genius product line. Cash used in
investing activities for the nine months ended September 30, 1999 was
attributable to the purchase of new office and computer equipment ($81,888) and
the development of Baby Genius production masters ($296,107) to extend our range
of titles.

         Net cash provided by financing activities was $1,237,850 and $1,759,087
for the nine months ended September 30, 2000 and September 30, 1999
respectively. For both periods cash provided by financing activities was
primarily attributable to proceeds from the issuance of common stock through
private placement offerings.

                           PART II--OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS

                  None

ITEM 2.  CHANGES IN SECURITIES AND USE OF PROCEEDS

         During the period from October 1, 2000 through the date of this filing,
we issued a total of 780,000 shares, of which (a) 100,000 shares registered
pursuant to the company's Form S-8 in connection with the company's Genius
Products, Inc. 2000 Non-Qualified Stock Option Plan (the "Plan"), were sold to a
consultant for services to the company upon exercise of certain options for
$0.20 per share for total net proceeds of $20,000, payable pursuant to a
promissory note, (b) 30,000 shares registered pursuant to the company's Form S-8
and the Plan, were sold to a consultant for services to the company upon
exercise of certain options for $0.18 per share, on a cashless basis, and in
consideration of the surrender of additional options for shares the aggregate
market price for which equaled the aggregate consideration of the exercise price
of the options exercised for the shares issued plus those surrendered, and (c)
650,000 restricted shares were issued at a price of $0.25 per share for net
proceeds of $162,500, to accredited investors pursuant to a private placement
under Regulation D of the 1933 Securities Act, as amended. All proceeds were
used for working capital purposes.

         As part of the company's policy of saving cash by paying partners,
outside service providers and consultants in options or other convertible
securities, during the period from October 1, 2000 through the date of this
filing, we granted options to a third party service provider to purchase 30,000
restricted shares at an exercise price of $0.20 per share for services to be
rendered. The right to exercise the option vested on the date of grant and
expires after one year. Under the agreement with the service provider, she will
be entitled to receive options to acquire up to maximum of 600,000 free trading
shares subject to meeting certain performance targets to be measured by the
market price of the company's common stock.

                                       9
<PAGE>

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

         None.



ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

         None.

ITEM 5.  OTHER INFORMATION

         None.

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

         (a)      EXHIBITS REQUIRED BY ITEM 601 OF REGULATION S-B

   Exhibit No.                                Description
   -----------                                -----------

2.1             Agreement and Plan of Reorganization with Salutations, Inc., and
                related exhibits and consents*
3.1             Articles of Incorporation, as amended*
3.2.1           Bylaws, as amended*
3.2.2           Bylaws, as amended on April 20, 2000****
4.2             Shareholders Agreement with Minnesota Communications Group, and
                related exhibits and schedules*
4.3             Convertible Debenture with Russ Karlen*
4.4             Convertible Debenture with Steve Livingston*
4.5             Option Agreement to Purchase Common Stock with Kevin Harrington
                Enterprises, Inc.*
4.6             Option agreement to Purchase Common Stock with Tim Harrington*
4.7             Form of Stock Option Agreement with Employees*
4.8             Specimen Certificate for Common Stock***
10.1            License Agreement with Minnesota Communications Group*
10.2            License Agreement with Minnesota Public Radio*
10.3            Spokesperson Agreement for Deidre Hall with Panache, Inc., and
                related exhibits and addendum thereto*
10.4            Sublease with Torrey Hills Corporate Center, and related
                exhibits*
10.5            Fulfillment Services Agreement with Professional Marketing
                Associates, Inc.*
10.6            Letter Agreement with Lido Group*
10.7            International Marketing and Distribution Agreement with HSND,
                and amendment and addendum thereto*
10.8            Non-Qualified Stock Option Plan*
10.9            Senior Executive Employment Agreement with Klaus Moeller*
10.10           Change of Control Executive Employment Agreement with Klaus
                Moeller*
10.11           Senior Executive Employment Agreement with Dorian Lowell*
10.12           Change of Control of Executive Employment Agreement with Dorian
                Lowell*
10.13           Senior Executive Employment Agreement with Michael Meader*
10.14           Change of Control of Executive Employment Agreement with Michael
                Meader*
10.15           Executive Employment Agreement with Larry Balaban*
10.16           Change of Control of Executive Employment Agreement with Larry
                Balaban*
10.17           Executive Employment Agreement with Howard Balaban*
10.18           Change of Control of Executive Employment Agreement with Howard
                Balaban*
10.19           Executive Employment Agreement with Vinko Kovac*
10.20           Change of Control of Executive Employment Agreement with Vinko
                Kovac*

                                       10
<PAGE>

   Exhibit No.                                Description
   -----------                                -----------

10.21           License Agreement with Sasha St. Clair*
10.22           Letter Agreement with Gerald Edick*
10.23           Form of License Agreement with Naxos of America, Inc.*
10.24           Financial Public Relations Letter of Agreement with Porter,
                LeVay & Rose, Inc.**
10.25           License Agreement with Boomerang Marketing, Inc/*
10.26           Service(s) Agreement with Cost Care, Inc. (dba Unicare Managed
                Care Services)**
10.27           Executive Employment Agreement with Alison Elliott***
10.28           Change of Control Agreement with Alison Elliott***
10.29           Consulting Agreement with Gerald Edick***
10.30           Production Agreement with Richard Perry*****
10.31           Representation Agreement with Global Icons*****
10.32           Consulting Agreement with Johnny Drummond+
10.33           Stock Option Agreement with Klaus Moeller+
10.34           Stock Option Agreement with Dorian Lowell+
10.35           Stock Option Agreement with Michael Meader+
10.36           Stock Option Agreement with Larry Balaban+
10.37           Stock Option Agreement with Howard Balaban+
10.38           Stock Option Agreement with Alison Elliott+
27              Financial Data Schedule

------------------
*        Incorporated by reference from the exhibits included with the Company's
         Registration Statement (No. 000-27915) on Form 10-SB filed with the SEC
         on November 2, 1999.
**       Incorporated by reference from the exhibits included with the Company's
         Registration Statement (No. 000-27915), Amendment No. 1, on Form 10-SB
         filed with the SEC on December 17, 1999.
***      Incorporated by reference from the exhibits included with the Company's
         Form 10-KSB (No. 000-27915) filed with the SEC on April 14, 2000.
****     Incorporated by reference from the exhibits included with the Company's
         Form 10-KSB (No. 000-27915), Amendment No. 1, filed with the SEC on May
         1, 2000.
*****    Incorporated by reference from the exhibits included with the Company's
         Form 10-QSB (No. 000-27915), Amendment No. 1, filed with the SEC on May
         18, 2000.
+        Incorporated by reference from the exhibits included with the Company's
         Form 10-QSB (No. 000-27915), filed with the SEC on August 14, 2000.

         (b)      REPORTS ON FORM 8-K

         None filed by the Company during the third quarter of the fiscal year
ending on December 31, 2000.


SIGNATURES

         In accordance with the requirements of the Exchange Act, the registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

                                            GENIUS PRODUCTS, INC.,
                                            a Nevada Corporation


November 20, 2000                           By: /s/ Klaus Moeller
                                            ------------------------------------
                                            Klaus Moeller, CEO and Interim CFO

                                       11